Joo, Pangyu
Kim, Minkyung
Kish, Brianna
Nair, Vidhya Vijayakrishnan
Tong, Yunjie
Liu, Ziyue
O’Brien, Andrew R. W.
Harte, Steven E.
Harris, Richard E.
Lee, UnCheol
Wang, Ying
Funding for this research was provided by:
National Institutes of Health (Grant # 4R00AT010012)
National Institute of General Medical Sciences (R21GM143521)
School of Medicine, Indiana University (Strategic Research Initiative funding)
Article History
Received: 28 November 2023
Accepted: 18 March 2024
First Online: 27 March 2024
Competing interests
: SEH has consulted for Aptinyx, Memorial Sloan Kettering Cancer Institute, University of North Carolina-Chapel Hill, Indiana University, and University of Glasgow, and has received research funding from NIH, Arbor Medical Innovations, and Aptinyx. REH has received grant funding from Pfizer, Aptinyx, and Cerephex and National Institutes of Health (NIH). The remaining authors declare no competing interests.